Context Androgen-deprivation therapy (ADT) is a key component of treatment for aggressive
and advanced prostate cancer, but it has also been associated with adverse effects on bone …

Background Evaluation of treatment options for localized prostate cancer (PCa) remains
among the highest priorities for comparative effectiveness research. Surgery and …

Introduction Because of improved prostate cancer detection, more patients begin androgen
deprivation therapy (ADT) earlier and remain on it longer than before. Patients now may be …

Background Patients with severe erectile dysfunction (ED) and penile size issues, especially
seen in Peyronie's disease (PD), are candidates for more invasive penile prosthesis …

Penile size is a considerable concern for men of all ages. Herein, we review the data on
penile size and conditions that will result in penile shortening. Penile augmentation …

Objective To present the feasibility and safety of penile length and girth restoration based on
a modified 'sliding'technique for patients with severe erectile dysfunction (ED) and significant …

There are more than 2 million prostate cancer survivors in the United States. Primary therapy
with surgery or radiation results in permanent changes in sexual function. More than half of …

Men with prostate cancer (PCa) frequently undergo androgen deprivation therapy (ADT),
typically in the form of a depot injection of luteinizing hormone-releasing hormone agonists …

Androgen deprivation therapy (ADT) has been an essential treatment option for treating
prostate cancer (PCa). The role for hormonal treatment initially was restricted to men with …

Aim To develop a management strategy (rehabilitation programme) for erectile dysfunction
(ED) after radiotherapy (RT) or androgen deprivation therapy (ADT) for prostate cancer that …